MP67-08 SURGICAL OUTCOMES OF ROBOT-ASSISTED RADICAL PROSTATECTOMY WITH THE NOVEL "HUGO" ROBOTIC SYSTEM: INITIAL 100 CASES PERFORMED AT A TERTIARY REFERRAL ROBOTIC CENTER CENTER

Abstract

You have accessJournal of UrologyCME1 Apr 2023MP67-08 SURGICAL OUTCOMES OF ROBOT-ASSISTED RADICAL PROSTATECTOMY WITH THE NOVEL "HUGO" ROBOTIC SYSTEM: INITIAL 100 CASES PERFORMED AT A TERTIARY REFERRAL ROBOTIC CENTER CENTER Marco Paciotti, Carlo Bravi, Angelo Mottaran, Adele Piro, Luca Sarchi, Maria Peraire Lores, Eleonora Balestrazzi, Luigi Nocera, Federico Piramide, Ruben De Groote, Geert De Naeyer, Frederiek D'Hondt, and Alexandre Mottrie Marco PaciottiMarco Paciotti More articles by this author , Carlo BraviCarlo Bravi More articles by this author , Angelo MottaranAngelo Mottaran More articles by this author , Adele PiroAdele Piro More articles by this author , Luca SarchiLuca Sarchi More articles by this author , Maria Peraire LoresMaria Peraire Lores More articles by this author , Eleonora BalestrazziEleonora Balestrazzi More articles by this author , Luigi NoceraLuigi Nocera More articles by this author , Federico PiramideFederico Piramide More articles by this author , Ruben De GrooteRuben De Groote More articles by this author , Geert De NaeyerGeert De Naeyer More articles by this author , Frederiek D'HondtFrederiek D'Hondt More articles by this author , and Alexandre MottrieAlexandre Mottrie More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003330.08AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: HUGO Robot-Assisted Surgery (RAS) system (Medtronic©, USA) has recently received CE mark approval for urological procedures. Herein, we described clinical outcomes of the first case series of robot-assisted radical prostatectomy (RARP) with the HUGO RAS system. METHODS: We analyzed data of 107 patients who received RARP±extended pelvic lymph-node dissection (ePLND) at OLV hospital (Aalst, Belgium). All procedures were performed by experienced robotic surgeons. We described peri-, post-operative and functional outcomes. Final pathology results were available for 100 patients. Continence was defined as the use of no/one safety pad. RESULTS: Median (interquartile range [IQR]) age was 65 (60, 70) years. Median (IQR) preoperative PSA level was 7.8 (5.6, 10.2) ng/ml. A total of 36 (34%) patients had International Society of Urologic Pathology (ISUP) group 3-5 tumors on prostate biopsy. On preoperative MRI, median (IQR) prostate volume was 40 (32, 55) ml, and twenty patients (19%) had a suspicion of extra-prostatic disease. All twelve validated steps of the procedure were completed, with no need for conversion or for additional ports placement. 28 (26%) patients received an ePLND. No intraoperative complication was recorded. Median (IQR) operative and console time were 180 (140, 200) and 150 (110, 180) minutes, respectively. Median (IQR) estimated blood loss was 450 (250, 550) ml. Median (IQR) postoperative day of removal of urethral catheter was 2 (2, 2) days. After surgery, one patient experienced an acute urinary retention that was treated with re-catheterization. Two patients had a Clavien-Dindo ≥2 postoperative complications. Median (IQR) length of stay was 3 (3, 4) days. On final pathology, 42 (42%) and 28 (28%) patients had ISUP group 3-5 tumors and evidence of extraprostatic extension, respectively. A total of 8 (8%) patients had positive surgical margins. A total of 77 and 45 patients had available data on urinary continence recovery at one and three months after surgery, respectively. One month after surgery, 49/77 (64%) patients were continent, whereas 41/45 (91%) recovered urinary continence 3 months after surgery. CONCLUSIONS: In this clinical investigation, we showed that RARP performed with the novel HUGO RAS system achieves optimal oncologic and functional outcomes. Further, multi-centric data are awaited to confirm these findings at longer follow-up, with respect to biochemical recurrence and erectile function recovery after surgery. Source of Funding: None © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e946 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Marco Paciotti More articles by this author Carlo Bravi More articles by this author Angelo Mottaran More articles by this author Adele Piro More articles by this author Luca Sarchi More articles by this author Maria Peraire Lores More articles by this author Eleonora Balestrazzi More articles by this author Luigi Nocera More articles by this author Federico Piramide More articles by this author Ruben De Groote More articles by this author Geert De Naeyer More articles by this author Frederiek D'Hondt More articles by this author Alexandre Mottrie More articles by this author Expand All Advertisement PDF downloadLoading ...